MORPHINE ADMINISTRATION

Similar documents
PCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING

CLINICAL POLICY FOR THE USE OF INTRANASAL DIAMORPHINE FOR ANALGESIA IN CHILDREN ATTENDING THE PAEDIATRIC EMERGENCY DEPARTMENT, SASH

Beyond The Lockout Time. Kelcy Freeman, PharmD, BCPS April 20, 2017 REMEDI Pump Collaborative Spring Conference Chicago, IL

Cardiac Catheter Labs Intravenous Drug Therapy Guide

Trust Guideline for the Management of Patient Controlled Analgesia (PCA) or Nurse Controlled Analgesia (NCA) in Children

Trust Guideline for the Management of Patient Controlled Analgesia (PCA) in Adults

Adult Policy for Strong Opioid Dosing (Acute Pain) Intermittent Oral and Subcutaneous Management

DBL NALOXONE HYDROCHLORIDE INJECTION USP

Care in the Last Days of Life

Surgical Care at the District Hospital. EMERGENCY & ESSENTIAL SURGICAL CARE

Drug Prescription and Administration Record

Supportive Care. End of Life Phase

AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS ABN

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain

DOCUMENT CONTROL PAGE

STARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION

CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259

DOCUMENT CONTROL PAGE

Analgesia. The modern approach. Dr. Mark Haworth MB.ChB.DA.MRCA.

Renal Palliative Care Last Days of Life

Effective Shared Care Agreement for the treatment of severe motor complications in people with Parkinson Disease with apomorphine (APO-go )

CHILDREN S SERVICES. Trust Medicines Policy and Procedures Paediatric Pain Assessment Chart

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

BJF Acute Pain Team Formulary Group

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)

Algorithms for Symptom Management. In End of Life Care

Guidelines on the Safe Practice of Acute Pain Management

Intraspinal (Neuraxial) Analgesia Community Nurses Competency Test

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

Pain Module. Top Ten Pain Safety Tips

Codeine and Paracetamol in Paediatric use, an Update 5 th October 2013

PARACOD Tablets (Paracetamol + Codeine phosphate)

GUIDELINES ON CONSCIOUS SEDATION FOR DENTAL PROCEDURES

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

SEDATION FOR SMALL PROCEDURES

Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July Gosport Hospital Report & RUH Assurance

Syringe driver in Palliative Care

SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults

FACULTY OF PAIN MEDICINE

Continuous Nitrous Oxide Sedation in Paediatrics

New Guidelines for Prescribing Opioids for Chronic Pain

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

DEEP SEDATION TEST QUESTIONS

2 hospital system, tertiary care, community, referral centers

5 MUSCULOSKELETAL SYSTEM

Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS)

DRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy)

** Medication exercises ** NICU Phase II

OBJECTIVES OF TRAINING FOR THE ANAESTHESIA TERM

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

Sedation in Children

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol

PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker

CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline

Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings

CLINICAL GUIDELINES ID TAG

Chapter 004 Procedural Sedation and Analgesia

PART 1.B SPC, LABELLING AND PACKAGE LEAFLET

PAIN MANAGEMENT Module 1 Patient Controlled Analgesia

Suboptimal hydration harms patients.

Symptom Management Guidelines for End of Life Care

Remifentanil PCA In Labor

ADULT (>16) ACUTE SICKLE PAIN GUIDELINE

Ketofol: risky or revolutionary: CPD article IV

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

PAIN PODCAST SHOW NOTES:

Perioperative Pain Management

Atropine Sulfate Injection

SUMMARY OF PRODUCT CHARACTERISTICS

Medicines Protocol RECTAL DIAZEPAM

Reducing the risk of patient harm: A focus on opioids

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

Michigan General Procedures PAIN MANAGEMENT Date: November 15, 2012 Page 1 of 7

GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

POLICY and PROCEDURE

patient group direction

Respiratory Depression

DATA SHEET. Product Summary. 1. Trade Name of Medicinal Product. Protamine Sulphate Injection BP. 2. Qualitative and Quantitative Composition

PHYSICIAN'S ORDERS Mark in for desired orders. If is blank, order is inactive. VENTILATOR SEDATION / ANALGESIC / DELIRIUM ORDER

Propofol 2% (20 mg/1 ml) MCT Fresenius emulsion for injection or infusion

GUIDELINES FOR THE USE OF NALOXONE INJECTION FEBRUARY 2018

Controlled Document Number: Version Number: 1. Controlled Document Sponsor: Controlled Document Lead (Author): On: July Review Date: July 2020

Farmadol. Paracetamol 10 mg/ml INFUSION SOLUTION

Implementing the WAT-1: an 11 item withdrawal assessment tool

Palliative care for heart failure patients. Susan Addie

Analgesia in patients with impaired renal function Formulary Guidance

Primary Diagnosis YES NO ICD - Code Cancer Cognitive impairment Cardiac Respiratory Neurological Musculoskeletal Respiratory Other

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Addendum D. Procedural Sedation Test MERCY MEDICAL CENTER- SIOUX CITY. Procedural Sedation Questions

Nurse anesthetists play a crucial role in the

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

1 (ix) Pain control. What responsibilities do you assume when you prescribe analgesia?

Opioid overdose versus opioid toxicity. Dr Colette Reid

Transcription:

Introduction Individualised Administration Drug of Choice Route of Administration & Doses Monitoring of Neonates & high risk patients Team Management Responsibility Morphine Protocol Flow Chart Introduction A standard for the administration of Intravenous Morphine should allow effective relief of pain with an acceptable nursing workload, while increasing patient safety. Individualised Administration In a children s hospital the need to individualise opioid therapy is particularly challenging because of the need to consider developmental issues in terms of both pharmacokinetics and pharmacodynamics. Of particular concern is the immaturity of elimination pathways and of ventilatory control in neonates. Drug of Choice Morphine is considered the gold standard opioid analgesic for management of pain in children unless contraindicated. A step-wise approach to managing pain should be considered for optimal pain management. Route of Administration & Doses The preferred route for Morphine administration is oral. This route is convenient, administration is painless and a number of preparations are available. Many patients who have acute pain will initially require Morphine by injection because either the oral route is contraindicated (e.g. vomiting, fasting, oral ulceration, or because a rapid response is needed. IV injections are preferred over intramuscular (IM) or intermittent subcutaneous (SC) injections for management of acute pain. This is because the IV effect is rapid and thus easily titrateable. In addition respiratory depression, if it occurs, will occur rapidly. In contrast, IM and SC administration may result in drug absorption that varies according to peripheral perfusion and the effects may be considerably delayed after administration. Intermittent IM injections to manage pain are painful and children may deny they have pain to avoid the needle. Continuous SC infusions are useful in palliative pain management when the IV or oral route is not appropriate. The IV route carries the risk of respiratory depression, but the use of a standardised protocol is expected to minimise the danger. Morphine Administration Page: 1 of 5

Morphine Bolus Administration Administering small boluses of Morphine every five minutes makes it possible to carefully titrate pain relief while observing for the side effects of sedation and respiratory depression. Usual Dose Range Infants < 6 months 0.02 mg/kg at 5 minute intervals Child over 6 months but < 50kg 0.04 mg/kg at 5 minute intervals Child over 50kg 2 mg at 5 minute intervals Larger doses may be required at times, but they remove the safety offered by titration and are hazardous in the absence of immediate availability of artificial ventilation. Initial Morphine Bolus Administration PICU/CED/OR Larger doses may initially be administered to children over 6 months of age as prescribed by medical staff on an individual basis in the Paediatric Intensive Care Unit (PICU)/ Children s Emergency Department (CED)/ and Operating Rooms (OR) where there is the immediate availability of artificial ventilation. For children over 6 months and less than 50kg the initial administration dose may be 0.1mg/kg. For children less than 6 months a usual initial dose would be 0.05mg/kg (50mcg/kg). For children over 50kg the initial administration dose may be a standard bolus of 5mg. Further doses may then be administered as per IV Morphine protocol. Smaller doses are advisable under some circumstances. Frequent Morphine Bolus Administration Vs PCA/ Continuous Opioid Infusions The disadvantage of repeated small doses is less adequate pain relief and the time demand upon nursing staff. If a child requires more than five titrations of morphine within a 25 minute period as described in this protocol and who is likely to have/ has on going pain, then a patient controlled analgesia (PCA) pump or a continuous opioid infusion should be considered. Usually Morphine is the drug of choice for PCA and continuous opioid infusions unless contraindicated. Alternative opioid analgesic modality prescriptions should be discussed with the Pain Service. Morphine Administration Page: 2 of 5

PCA has a clear safety record provided it is programmed correctly and only the patient presses the button. The inherent safety of PCA arises because a patient will become sedated if the demand button is pressed too often and thus the patient will stop pressing it. PCA, using a non-return valve is the preferred device for children who understand the concept and are physically able to use it. This includes most school-aged children. At times a background infusion may be programmed using this modality. PCA prescription/ modality access is via the Pain Service. These children will require observation monitoring as per PCA prescription chart and RBP. A syringe driver, using a non-return valve is the preferred device for a continuous opioid infusion in children unsuitable for PCA use. Devices such as burettes and simple volumetric pumps are not used for this purpose. Continuous opioid prescription / modality access is via the Pain Service. These children will require observation monitoring as per continuous opioid infusion prescription chart and RBP. Monitoring of Neonates and At Risk Patients Neonates in particular and infants less than 6 months of age have an increased risk of opioid induced respiratory depression. Infants less than 6 months of age must have continuous respiratory monitoring after opioid administration. The preferred monitor is a pulse oximeter. An apnoea alarm is a suitable alternative. There must be a nurse available to respond to the monitor. Monitoring must continue after the last opioid administration. The period of observation should be: Infants < 1month = 9 hours Infants >1month to 6 months of age = 4 hours Special consideration should be taken of ex-premature infants with a post conceptual age of less than 60 weeks. These infants will require continuous observation until they have a 24 hour apnoea free period. Caution should also be taken in morphine administration in children with known renal impairment. Children with renal impairment have the potential to accumulate morphine metabolites and therefore have an increase risk of respiratory depression and sedation. It is advisable that consultation with Senior Medical Staff occurs prior to the administration of morphine. Other children at high risk of respiratory depression that may require continuous monitoring while receiving opioids include: central neurological diseases sleep apnoea pre - existing respiratory failure renal impairment children receiving sedatives (i.e. diazepam Morphine Administration Page: 3 of 5

Team Management The primary team should manage patients receiving Morphine via the Morphine protocol. Patients who require consideration for a PCA/ Continuous Opioid Infusion should be referred to the Pain Service after consultation with the primary team. Responsibility All Registered Nursing Staff who have completed the competency for Intravenous administration of Morphine and who are currently assessed as competent for IV/medication administration. Morphine Protocol Flow Chart Prescribe in the patient s medication chart as Morphine as per IV Protocol The medication will be administered by Registered Nursing Staff who have completed the competency for Intravenous administration of Morphine and who are currently assessed as competent for IV/medication administration. The flow chart on the following page will enable safe administration of intravenous Morphine. Morphine Administration Page: 4 of 5

Child has moderate / severe Pain? Only to be administered by an (IV) Registered Nurse who has completed the morphine administration competency or a medical practitioner. Morphine as per IV Protocol prescribed in medication chart. Call primary team Prepare Morphine in a 10ml syringe: 0.2mg per kg morphine made up to 10mls with 0.9% NaCl. Child weighs 50kg or over? Prepare Morphine in a 10ml syringe: 10 mg morphine made up to 10 mls with 0.9% NaCl Child s age is 6 months or less? Rousable to voice, or light touch Respiratory rate > 30 neonate >20 infant Heart rate is appropriate Rousable to voice Respiratory rate > 20 infant > 15 toddler / child and older Heart Rate is appropriate Rousable to voice Repiratory rate > 15 Heart rate is appropriate Administer 1 ml IV from the syringe. 1ml= 0.02mg per kg Administer 2 ml IV from the syringe. 2ml = 0.04mg per kg Administer 2 ml IV from the syringe. 2ml= 2mg Wait 5 minutes Child has moderate / severe pain? Has 5 cycles of this flow chart been administered in 25 minutes? Call Primary Team and Pain Service Different procedure for Resuscitation Room in Children s Emergency Department (refer page 1) Morphine Administration Page: 5 of 5